Y. ISOMURA

630 total citations
25 papers, 506 citations indexed

About

Y. ISOMURA is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, Y. ISOMURA has authored 25 papers receiving a total of 506 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Organic Chemistry, 5 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Y. ISOMURA's work include Synthesis of heterocyclic compounds (9 papers), Synthesis and biological activity (9 papers) and Synthesis and Characterization of Heterocyclic Compounds (8 papers). Y. ISOMURA is often cited by papers focused on Synthesis of heterocyclic compounds (9 papers), Synthesis and biological activity (9 papers) and Synthesis and Characterization of Heterocyclic Compounds (8 papers). Y. ISOMURA collaborates with scholars based in Japan and United States. Y. ISOMURA's co-authors include Yutaka Ebizuka, Shoji Shibata, Motoko Inomata, Fumiko Fukuoka, Ushio Sankawa, Hideaki Otsuka, Kazuo Kubo, Tadao Shibanuma, Koyo Matsuda and Toshiyasu Mase and has published in prestigious journals such as Journal of Medicinal Chemistry, Tetrahedron and Bioorganic & Medicinal Chemistry Letters.

In The Last Decade

Y. ISOMURA

23 papers receiving 471 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Y. ISOMURA Japan 12 276 197 110 72 70 25 506
Charles W. Shansky United States 6 136 0.5× 145 0.7× 110 1.0× 43 0.6× 31 0.4× 10 330
Sheng Chu Kuo Taiwan 11 476 1.7× 225 1.1× 55 0.5× 50 0.7× 110 1.6× 18 697
Fumio Satoh Japan 12 231 0.8× 161 0.8× 51 0.5× 21 0.3× 75 1.1× 53 417
Marco Ghia Italy 13 595 2.2× 219 1.1× 30 0.3× 56 0.8× 85 1.2× 44 928
Sidney Goodwin United States 11 240 0.9× 242 1.2× 64 0.6× 53 0.7× 58 0.8× 14 509
Michel Souchet France 13 186 0.7× 227 1.2× 43 0.4× 88 1.2× 48 0.7× 22 514
Annalina Lapucci Italy 16 446 1.6× 307 1.6× 32 0.3× 54 0.8× 135 1.9× 53 749
John C. Sih United States 13 381 1.4× 234 1.2× 20 0.2× 52 0.7× 71 1.0× 30 609
Seung Kyu Kang South Korea 17 567 2.1× 285 1.4× 43 0.4× 101 1.4× 58 0.8× 43 929
Yasuyoshi Miki Japan 18 763 2.8× 263 1.3× 53 0.5× 25 0.3× 98 1.4× 102 1.0k

Countries citing papers authored by Y. ISOMURA

Since Specialization
Citations

This map shows the geographic impact of Y. ISOMURA's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y. ISOMURA with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y. ISOMURA more than expected).

Fields of papers citing papers by Y. ISOMURA

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Y. ISOMURA. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y. ISOMURA. The network helps show where Y. ISOMURA may publish in the future.

Co-authorship network of co-authors of Y. ISOMURA

This figure shows the co-authorship network connecting the top 25 collaborators of Y. ISOMURA. A scholar is included among the top collaborators of Y. ISOMURA based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Y. ISOMURA. Y. ISOMURA is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ogihara, Takuo, Makoto Ozawa, Takuya Fujita, et al.. (2006). What Kinds of Substrates Show P-Glycoprotein-Dependent Intestinal Absorption? Comparison of Verapamil with Vinblastine. Drug Metabolism and Pharmacokinetics. 21(3). 238–244. 54 indexed citations
2.
Kimura, Masaaki, Hironobu Mitani, & Y. ISOMURA. (2002). Preclinical and clinical profile of valsartan, a selective angiotensin II type-1 receptor blocker.. Folia Pharmacologica Japonica. 120(5). 353–360. 3 indexed citations
3.
Kubota, Hirokazu, Yoshinori Okamoto, Masahiro Fujii, et al.. (1998). Synthesis and NK1 receptor antagonistic activity of (±)-1-Acyl-3-(3,4-dichlorophenyl)-3-[2-(spiro-substituted piperidin-1′-yl)ethyl]piperidines. Bioorganic & Medicinal Chemistry Letters. 8(12). 1541–1546. 8 indexed citations
4.
Semple, Graeme, Doreen M. Ashworth, Andrew Baxter, et al.. (1998). Peptidomimetic aminomethylene ketone inhibitors of interleukin-1β-converting enzyme (ICE). Bioorganic & Medicinal Chemistry Letters. 8(8). 959–964. 27 indexed citations
5.
Nakahara, Hidehiro, et al.. (1998). Absolute Configuration of (+)-1-Phenyl-1,2,3,4-tetrahydroisoquinoline Hydrochloride. Acta Crystallographica Section C Crystal Structure Communications. 54(5). 651–653.
6.
Semple, Graeme, Doreen M. Ashworth, Andrew Baxter, et al.. (1997). PYRIDONE-BASED PEPTIDOMIMETIC INHIBITORS OF INTERLEUKIN-1β-CONVERTING ENZYME (ICE). Bioorganic & Medicinal Chemistry Letters. 7(10). 1337–1342. 25 indexed citations
7.
Matsuda, Koyo, Isao Yanagisawa, Y. ISOMURA, Toshiyasu Mase, & Tadao Shibanuma. (1997). Alternative Synthesis of Dibenzo-and Dipyrido-[1,3]Diazepines from Thioamides and o,o′-Diaminobiaryls. Synthetic Communications. 27(14). 2393–2402. 16 indexed citations
8.
Kobayashi, Seiji, Ken‐ichi Ikeda, Makoto Takeuchi, et al.. (1996). Effects of antimuscarinics on urinary bladder and salivary gland. The Japanese Journal of Pharmacology. 71. 328–328. 1 indexed citations
10.
Arima, Hideki, Tadao Kojima, Y. ISOMURA, et al.. (1986). Stereoselectivity of a potent calcium antagonist, 1-benzyl-3-pyrrolidinyl methyl 2,6-dimethyl-4-(m-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate. Journal of Medicinal Chemistry. 29(12). 2504–2511. 78 indexed citations
11.
Takenaka, Toichi, Osamu Inagaki, Michio Terai, et al.. (1985). Stereospecificity of dihydropyridine calcium channel blocking drugs, nicardipine (NIC) and YM-09730 (YM).. The Japanese Journal of Pharmacology. 39. 215–215. 2 indexed citations
13.
ISOMURA, Y., et al.. (1984). Synthesis and anti-inflammatory activity of 2,6-di-tert-butylphenols with a heterocyclic group at the 4-position. III.. Chemical and Pharmaceutical Bulletin. 32(1). 152–165. 13 indexed citations
14.
ISOMURA, Y., et al.. (1983). Studies on the synthesis and anti-inflammatory activity of 2,6-di-tert-butylphenols with a heterocyclic group at the 4-position. I.. Chemical and Pharmaceutical Bulletin. 31(9). 3168–3178. 27 indexed citations
15.
ISOMURA, Y., et al.. (1983). Studies on the synthesis and anti-inflammatory activity of 2,6-di-tert-butylphenols with a heterocyclic group at the 4-position. II.. Chemical and Pharmaceutical Bulletin. 31(9). 3179–3185. 7 indexed citations
16.
17.
Kubo, Kazuo, et al.. (1979). Studies on the Syntheses of 2 (1H)-Pyridone Derivatives. III. Synthesis of 6-Amino-2 (1H)-pyridones and Their Cyclization. YAKUGAKU ZASSHI. 99(8). 788–793. 3 indexed citations
18.
Kubo, Kazuo, et al.. (1979). Studies on the Syntheses of 2 (1H)-Pyridone Derivatives. IV. Synthesis of Condensed Heterocyclic 2 (1H)-Pyridones. YAKUGAKU ZASSHI. 99(9). 880–888. 15 indexed citations
19.
20.
Sankawa, Ushio, Yutaka Ebizuka, Y. ISOMURA, et al.. (1977). Antitumor activity of shikonin and its derivatives.. Chemical and Pharmaceutical Bulletin. 25(9). 2392–2395. 142 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026